SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension.

Autor: Walters, Rachel, Vasilaki, Eleni, Aman, Jurjan, Chen, Chien-Nien, Wu, Yukyee, Liang, Olin D., Ashek, Ali, Dubois, Olivier, Zhao, Lin, Sabrin, Farah, Cebola, Inês, Ferrer, Jorge, Morrell, Nicholas W., Klinger, James R., Wilkins, Martin R., Zhao, Lan, Rhodes, Christopher J.
Zdroj: Circulation; 5/23/2023, Vol. 147 Issue 21, p1606-1621, 16p
Databáze: Complementary Index